Disability in a community population with MS with and without mental disorders

International Journal of Psychiatry in Medicine

Volumn 43, Issue 1, 2012, Pages 51-65

  Patten, Scott ^a   Williams, Jeanne ^a   Lavorato, Dina ^a   Metz, Luanne ^a   Bulloch, Andrew ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

cross sectional studies; disability; epidemiologic studies; mental disorders; multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGILITY; ARTICLE; CANADA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISABILITY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL DISEASE; MULTIPLE SCLEROSIS; PAIN; POPULATION RESEARCH; PREVALENCE; SELF REPORT; SOCIAL PARTICIPATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; VISION;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGE FACTORS; ALBERTA; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MENTAL DISORDERS; MIDDLE AGED; MULTIPLE SCLEROSIS; SEX FACTORS; SICK ROLE; YOUNG ADULT;

EID: 84859027620     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.43.1.d     Document Type: Article

References (39)

1. Murray TJ. Diagnosis and treatment of multiple sclerosis. British Medical Journal 2006;332:525-527.
2. Nicholas R, Chataway J. Multiple sclerosis. Clinical Evidence (Online) 2009; 2009: 1202. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC2907805
3. Patten SB, Beck CA, Williams JVA, Barbui C, Metz L. Major depression in multiple sclerosis: A population-based perspective. Neurology 2003;61:1524-1527.
4. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. General Hospital Psychiatry 1987;9:426-434.
5. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Mood disorders and multiple sclerosis. Archives of Neurology 1987;44:376-378.
6. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IML, Eisen K, et al. Depression and multiple sclerosis. Neurology 1996;46:628-632.
7. Galeazzi GM, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, et al. Psychiatric disorders and depression in multiple sclerosis outpatients: Impact of disability and interferon beta therapy. Neurological Science 2005;26:255-262.
8. Schiffer RB, Wineman NM, Weitkamp LR. Association between bipolar affective disorder and multiple sclerosis. American Journal of Psychiatry 1986;143:94-95.
9. Patten SB, Svenson LW, Metz LM. Psychotic disorders in MS: Population-based evidence of an association. Neurology 2005;1123-1125.
10. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Multiple Sclerosis 2007;13:67-72.
11. Dahl OP, Stordal E, Lydersen S, Midgard R. Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway. Multiple Sclerosis 2009;15:1495-1501.
12. Sadovnick AD, Eisen K, Ebers GC, Paty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991;41:1193-1196.
13. Brønnum-Hansen H, Stenager E, Stenager EN, Koch-Henriksen N. Suicide among Danes with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2005;76:1457-1459.
14. Koch-Henriksen N, Bronnum-Hansen H, Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: Results from the Danish Multiple Sclerosis Registry. Journal of Neurology, Neurosurgery and Psychiatry 1998;65:56-59.
15. Stenager EN, Stenager E, Koch-Henriksen N, Bronnum-Hansen H, Hyllested K, Jensen K, et al. Suicide and multiple sclerosis: An epidemiological investigation. Journal of Neurology, Neurosurgery and Psychiatry 1992;55:542-545.
16. Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004; 62:586-590.
17. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biology and Psychiatry 2009; 65(9):732-741.
18. Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP. Treatment of depression is associated with suppression of nonspecific and antigen-specific T-H1 responses in multiple sclerosis. Archives of Neurology 2001;58:1081-1086.
19. Ysrraelit MC, Gaitan MI, Lopez AS, Correale J. Impaired hypothalamic-pituitary- adrenal axis activity in patients with multiple sclerosis. Neurology 2008;71:1948-1954.
20. Then BF, Kumpfel T, Grasser A, Rupprecht R, Holsboer F, Trenkwalder C. Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: A randomized, double blind trial. Journal of Clinical Endocrinology and Metabolism 2001;86:1610-1615.
21. Mostert JP, Admiraal-Behloul F, Hoogduin JM, Luyendijk J, Heersema DJ, van Buchem MA, et al. Effects of fluoxetine on disease activity in relapsing multiple sclerosis: A double-blind, placebo-controlled, exploratory study. Journal of Neurology, Neurosurgery and Psychiatry 2008;79:1027-1031.
22. Statistics Canada. Overview of the Census. 2010. Ottawa, Statistics Canada. 2006 Census Dictionary.
23. Statistics Canada. 2006 Census Long Form. 2010. Ottawa, Statistics Canada.
24. Statistics Canada. Participation and Activity Limitation Survey (PALS). 2010. Ottawa, Statistics Canada.
25. Statistics Canada. The 2006 Participation and Activity Limitation Survey: Disability in Canada. Data collection. 2010. Ottawa, Statistics Canada.
26. Statistics Canada. Partication and Activity Limitation Survey 2006: Technical and Methodological Report. Catalogue no. 89-628-XIE. 2007. Ottawa, Statistics Canada.
27. Stata Corporation. Stata, version 11.0. [11.0]. 2009. College Station, TX, Stata Corporation.
28. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI): Concepts, measurement properties and applications. Health Quality of Life Outcomes 2003;1:54.
29. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. Journal of Neurology, Neurosurgery and Psychiatry 2005;76:58-63.
30. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability scale (EDSS). Neurology 1983;33:1444-1452.
31. Khan F, McPhail T, Brand C, Turner-Stokes L, Kilpatrick T. Multiple sclerosis: Disability profile and quality of life in an Australian community cohort. International Journal of Rehabilitation Research 2006;29:87-96.
32. Ytterberg C, Johansson S, Gottberg K, Holmqvist LW, von KL. Perceived needs and satisfaction with care in people with multiple sclerosis: A two-year prospective study. BMC Neurology 2008;8:36.
33. Solari A, Radice D. Health status of people with multiple sclerosis: A community mail survey. Neurology Science 2001;22:307-315.
34. Gottberg K, Einarsson U, Ytterberg C, de Pedro CJ, Fredrikson S, von KL, et al. Health-related quality of life in a population-based sample of people with multiple sclerosis in Stockholm County. Multiple Sclerosis 2006;12:605-612.
35. Svendsen KB, Jensen TS, Overvad K, Hansen HJ, Koch-Henriksen N, Bach FW. Pain in patients with multiple sclerosis: A population-based study. Archives of Neurology 2003;60:1089-1094.
36. Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D'Aleo G, et al. The prevalence of pain in multiple sclerosis: A multicenter cross-sectional study. Neurology 2004;63:919-921.
37. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns, and prediction. Neurology 1991;41:685-691.
38. Goverover Y, Chiaravalloti N, DeLuca J. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Multiple Sclerosis 2005;11:203-212.
39. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurology 2010;9:520-532.